Skip to Content
  • Previous Rank
    147
  • Revenues ($M)
    $20,776.00
  • Revenue Percent Change
    6.9%
  • Profits ($M)
    $1,007.00
  • Profits Percent Change
    -77.4%
  • Assets ($M)
    $33,551.00
  • Employees
    23,700
  • Market Value — as of March 29, 2018 ($M)
    $103,415.30

The biopharmaceutical company manufactures medicines for Alzheimer’s, dementia, pyschiatric disorders, cardiovascular, diabetes, oncology, and hepatitis.

41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

CEO
Giovanni Caforio
CEO Title
Chairman & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
New York City
Websitehttp://www.bms.com
Years on Fortune 500 List24
Employees23,700

Bristol-Myers Squibb Rank History

placeholder

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$20,776.006.9%
Profits ($M)$1,007.00-77.4%
Assets ($M)$33,551.00-
Total Stockholder Equity ($M)$11,741.00-
Market Value — as of March 29, 2018 ($M)$103,415.30-

Profit Ratios

Profit as % of Revenues4.8%
Profits as % of Assets3%
Profits as % of Stockholder Equity8.6%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)0.61
EPS % Change (from 2016)-77%
EPS % Change (5 year annual rate)-12.1%
EPS % Change (10 year annual rate)-5.6%

Total Return

Total Return to Investors (2017)7.8%
Total Return to Investors (5 year, annualized)16.6%
Total Return to Investors (10 year, annualized)13%